Allianz Global Investors is backing UDG Healthcare's decision to accept an improved and final £2.76bn takeover by Clayton, Dubilier & Rice (CD&R).
Allianz Global Investors, which holds an 8.6% stake, said that an improved offer of £10.80 for the FTSE 250 pharmaceuticals industry services group from Clayton, Dubilier & Rice would "better reflect the fair value of UDG's shares". The initial offer of £10.23, made in May, was opposed by major shareholders Allianz Global Investors and M&G, which said it undervalued the company. Allianz GI appoints M&G's Brown as UK distribution head Rory Alexander, a fund manager at M&G, last week said while the group was "pleased" that CD&R had upped its bid, "a potential offer of £10.80 would ...
To continue reading this article...
Join Investment Week for free
Signup and gain exclusive members-only insights - all free of charge!
- Unlimited access to real-time news, analysis and opinion from the investment industry, including the Sustainable Hub covering fund news from the ESG space
- Get ahead of regulatory and technological changes affecting fund management
- Important and breaking news stories selected by the editors delivered straight to your inbox each day
- Weekly members-only newsletter with exclusive opinion pieces from leading industry experts
- Be the first to hear about our extensive events schedule and awards programmes
